Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2024 01:15 ET | Source: Novartis Pharma AG

Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis

Continuous Kesimpta® treatment for up to six years showed sustained efficacy in recently diagnosed (≤3 years) treatment-naïve people living with relapsing multiple sclerosis (RMS) in an analysis...
February 27, 2024 03:18 ET | Source: Research and Markets

Artificial Intelligence / AI in Drug Discovery Research Report 2023 - Global Forecast to 2028: Market to Grow by $4 Billion, at a CAGR of 40.2%

Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence / AI in Drug Discovery Market by Offering, Process (Target selection, Validation, Lead Generation, Optimization), Drug Design...
January 24, 2024 09:12 ET | Source: Research and Markets

Emerging Drug Insight and Market Forecasts for YG1699 in Type 1 Diabetes Mellitus, 2019-2023 and 2023-2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "YG1699 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Understanding the future market...
October 11, 2023 14:29 ET | Source: Synfini

Peter Madrid, Head of Scientific Discovery at Synfini, Joins Other Expert Speakers to Lead a National Academies of Sciences Workshop on AI for Scientific Discovery

MENLO PARK, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Synfini, Inc., a pioneer in agile chemistry whose advanced, automated molecular discovery platform is transforming drug discovery, today...
September 29, 2023 05:03 ET | Source: Research and Markets

Global CADD Market Expected to Reach $7.81 Billion by 2030, Driven by Growing Demand for Advanced Drug Discovery

Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Computer-aided Drug Discovery Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ...
August 08, 2023 04:43 ET | Source: Research and Markets

Technology-enabled Drug Discovery Research Report 2023: AI Integration into Drug Discovery Remains on an Upward Trajectory, Increasing Almost 40% as of 2022

Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Growth Indicators for Technology-enabled Drug Discovery" report has been added to ResearchAndMarkets.com's offering. Innovative Business Models...
May 12, 2023 16:39 ET | Source: InSilico Medicine

Insilico Medicine Founder and CEO to Give Keynote on Disease Modeling with AI at PEGS Boston

Abu Dhabi, May 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine, a generative artificial intelligence (AI)-driven drug discovery company, announced that Alex Zhavoronkov, PhD, founder and CEO of the...
March 16, 2023 05:53 ET | Source: Research and Markets

Outlook on the Deep Learning Drug Discovery and Diagnostics Global Market to 2035: by Therapeutic Areas and Key Geographical Regions

Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Deep Learning Market in Drug Discovery and Diagnostics: Distribution by Therapeutic Areas and Key Geographical Regions: Industry Trends and Global...
March 01, 2023 10:28 ET | Source: Research and Markets

Global In-Silico Drug Discovery Market Report 2022: Industry Outlook and Demand Forecast to 2030 Featuring In-silico Medicine, Evotec, Charles River Labs, WuXi AppTec, Ligand Pharma, Simulation Plus

Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Global In-Silico Drug Discovery Market Report: By Product, Workflow, Technology, End-user - Industry Outlook and Demand Forecast to 2030" report has...
February 08, 2023 09:00 ET | Source: InSilico Medicine

Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, today announced that...

Next Page keyboard_arrow_right